BiosCompass has fifteen years of experience and expertise in the field of surgical adhesion prevention. However, the urgent need was recognized more than a decade earlier by one of BiosCompass's founders who helped pioneer the use of miniature fiberoptic endoscopes for intraspinal and intracranial procedures. One of those procedures was spinal myeloscopy via the sacral hiatus to visualize post-operative adhesions impinging nerve roots and causing pain, often debilitating pain. Furthermore, that continuing pain often led to secondary surgeries which often only resulted in more adhesions causing even worse pain.
The mission with myeloscopy was to manually break through the adhesions if possible, apply a lysing agent aimed to dissolve them, then administer a steroid to reduce inflammation and relieve the pain caused by the adhesions compressing a nerve root. That was then. Now the mission of BiosCompass is to PREVENT post-operative surgical adhesions.
Our AntiAD© range of surgical adhesion prevention gels are the result of many years of dedication to eliminating fibroblastic adhesions traditionally associated with all forms of surgery, even minimally invasive.<br>
BiosCompass is a biomedical company ready today for the current demands of advanced post-operative patient care and the ever increasing demands of tomorrow. We know that adhesion prevention alone is a worthy mission; however, our AntiAD© range provides more than a barrier against adhesion formation. AntiAD© redirects fibroblasts to arrange in a smooth plane that allows for proper healing. This speaks for BiosCompass also. Because while we are dedicated to surgical adhesion prevention, we believe that includes post- surgical pain reduction, extra-cellular matrix tissue regeneration, promotion of healing, lubrication for enhanced mobility, and restoration of health and well-being.
Bios is Life. Compass is for Direction. Life is about Healing. BiosCompass is the Direction for Healing Today.
Jon Rousu
Jon Rousu serves as the Executive Vice President of Operations. Mr. Rousu has more than 32 years of experience in neurosurgery field and international business development. After leaving the R&D field within IBM in the late 1980’s he moved to the medical field. He was General Manager of COMPASS International, Inc. for more than 10 years and is now CEO of COMPASS International. He has aided in the development of many new products in the neurosurgery arena during this time and has developed world wide distribution for many of these products.
Mr. Rousu is a Minnesota native and has traveled the world representing the neurosurgery field giving talks and presentations across the globe. He is the published author of numerous clinical and technical articles on stereotactic neurosurgery. He is a member of several Civic/Professional Organizations. He has a B.A.S. in Electronic Engineering from the University of Minnesota and a Mini MBA in Medical Technology from St. Olaf College.
Fred Hardwick
Fred Hardwick is the President and CEO of BiosCompass. Mr. Hardwick has more than 40 years of experience in medical/surgical fields and international business development. He founded Fred Hardwick Surgical, Inc. and Bios, LLC, focusing on surgical sales for neurosurgery, orthopaedics and interventional pain management. He also specialized in contract operating room service for frame-based and image guided stereotactic intracranial surgery for brain tumors. Hardwick provided stereotactic surgical service for Dr. Evan Zeiger and Dr. Robert Craddock of Carraway Methodist Medical Center, Birmingham, Alabama, for ten years using the Compass International stereotactic systems and the navigational techniques developed by Dr. Patrick Kelly of Mayo Clinic and New York University Hospital.
Hardwick’s work with Dr. Evan Zeiger included helping pioneer intracranial and intraspinal endoscopic procedures with miniature fiber optic endoscopes. Together, they held workshops to teach neurosurgeons from across the U.S. how to do endoscopic third ventriculostomies, remove colloidal cysts in the third ventricle, as well as endoscopic choroid plexectomies with holmium-yag laser. Hardwick also partnered with Dr. Roy Bakay, then at Emory University, to teach Georgia neurosugeons how to do endoscopic procedures in the third ventricle.
Hardwick’s early interest in spinal adhesions led to his helping to develop myeloscopes for lysing or medicating that tissue via the sacral hiatus and relieving pain. He is also the co-inventor of the Zeiger-Hardwick Scope and procedure for alleviating pain from trigeminal neuralgia. Realizing the major role biologics will have in the best of tomorrow's healthcare and the prevention of pain due to surgical adhesions, Mr. Hardwick has devoted years to tracking the development of many of these technologies with the aim of bringing them to the world's surgeons and their patients. That is the mission of BiosCompass, Inc.
Mr. Hardwick is an Alabama native. He has written about comparative world medicine, the history of the war against cancer, and pioneering endoscopic neurosurgery. In October of 2021 he had two pieces published in the Los Angeles Review of Books. Fred has been the featured speaker at civic group meetings and has spoken to corporate surgical sales forces about selling in the clinical, surgical setting. He has a B.A. degree from the University of Alabama.